Dr. Aravindhan Veerapandiyan
Claim this profileArkansas Children's Hospital
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
13 reported clinical trials
10 drugs studied
Area of expertise
1Muscular Dystrophy
DMD negative
DMD positive
DMD gene mutation exons 18+ positive
2Duchenne Muscular Dystrophy
DMD negative
DMD positive
DMD gene mutation exons 18+ positive
Affiliated Hospitals
Clinical Trials Aravindhan Veerapandiyan is currently running
Gene Therapy
for Duchenne Muscular Dystrophy
The study will evaluate the safety and efficacy of delandistrogene moxeparvovec gene transfer therapy in non-ambulatory and ambulatory males with DMD. This is a randomized, double-blind, placebo-controlled 2-part study. Participants will be in the study for approximately 128 weeks. All participants will have the opportunity to receive intravenous (IV) delandistrogene moxeparvovec in either Part 1 or Part 2.
Recruiting1 award Phase 35 criteria
Ribitol
for Limb-Girdle Muscular Dystrophy
This trial will test the safety and effectiveness of BBP-418 in patients aged 12 to 60 who have a specific type of muscular dystrophy called LGMD2I/R9. The goal is to see if this new treatment can help improve their condition over several months.
Recruiting1 award Phase 36 criteria
More about Aravindhan Veerapandiyan
Clinical Trial Related1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Aravindhan Veerapandiyan has experience with
- Placebo
- Tideglusib
- SRP-9001 (Delandistrogene Moxeparvovec)
- Lasmiditan
- Corticosteroids
- Pamrevlumab
Breakdown of trials Aravindhan Veerapandiyan has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Myotonic Dystrophy
Limb-Girdle Muscular Dystrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aravindhan Veerapandiyan specialize in?
Aravindhan Veerapandiyan focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved DMD negative patients, or patients who are DMD positive.
Is Aravindhan Veerapandiyan currently recruiting for clinical trials?
Yes, Aravindhan Veerapandiyan is currently recruiting for 7 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Aravindhan Veerapandiyan has studied deeply?
Yes, Aravindhan Veerapandiyan has studied treatments such as Placebo, Tideglusib, SRP-9001 (Delandistrogene Moxeparvovec).
What is the best way to schedule an appointment with Aravindhan Veerapandiyan?
Apply for one of the trials that Aravindhan Veerapandiyan is conducting.
What is the office address of Aravindhan Veerapandiyan?
The office of Aravindhan Veerapandiyan is located at: Arkansas Children's Hospital, Little Rock, Arkansas 72202 United States. This is the address for their practice at the Arkansas Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.